Spinocerebellar ataxia type 1

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 399-421

  Donato, Stefano Di ^a   Mariotti, Caterina ^a   Taroni, Franco ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961136585     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00025-5     Document Type: Chapter

References (160)

1. Abele M., Bürk K., Andres F., et al. Autosomal dominat cerebellar ataxia type 1. Nerve conduction and evoked potential studies in families with SCA1, SCA2, and SCA3. Brain 1997, 120:2141-2148.
2. Arrasate M., Mitra S., Schweitzer E.S., et al. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431:805-810.
3. Banfi S., Servadio A., Chung M.Y., et al. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat Genet 1994, 7:513-520.
4. Basu P., Chattopadhyay B., Gangopadhaya P.K., et al. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7, and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2, and SCA6 loci in nine ethnic population of Eastern India. Hum Genet 2000, 106:597-604.
5. Becher M.W., Kotzuk J.A., Sharp A.H., et al. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol Dis 1998, 4:387-397.
6. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292:1552-1555.
7. Berke S.J., Paulson H.L. Protein aggregation and the ubiquitin proteasome pathway: gaining the upper hand on neurodegeneration. Curr Opin Genet Dev 2003, 13:253-261.
8. Bird T.D. Hereditary Ataxia Overview, Online. Available:, (last revision, 8 November 2005). http://www.geneclinics.org.
9. Bowman A.B., Yoo S.Y., Dantuma N.P., et al. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 2005, 14:679-691.
10. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
11. Brusco A., Gellera C., Cagnoli C., et al. Molecular genetics of hereditary spinocerebellar ataxia. Mutational analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 2004, 61:727-733.
12. Bryer A., Krause A., Bill P., et al. The hereditary adult-onset ataxias in South Africa. J Neurol Sci 2003, 216:47-54.
13. Bürk K., Abele M., Fetter M., et al. Autosomal dominant cerebellar ataxia type I: clinical features and MRI in families with SCA1, SCA2, and SCA3. Brain 1996, 119:1497-1505.
14. Bürk K., Fetter M., Abele M., et al. Autosomal dominant cerebellar ataxia type I: oculomotor abnormalities in families with SCA1, SCA2, and SCA3. J Neurol 1999, 246:789-797.
15. Bürk K., Globas C., Bösch S., et al. Cognitive deficits in spinocerebellar ataxia type1, 2, and 3. J Neurol 2003, 250:207-211.
16. Burright E.N., Clark H.B., Servadio A., et al. SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell 1995, 82:937-948.
17. Burright E.N., Davidson J.D., Duvick L.A., et al. Identification of a self-association region within the SCA1 gene product, ataxin-1. Hum Mol Genet 1997, 6:513-518.
18. Chai Y., Koppenhafer S.L., Shoesmith S.J., et al. Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum Mol Genet 1999, 8:673-682.
19. Chai Y., Berke S.S., Cohen R.E., et al. Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 2004, 279:3605-3611.
20. Chen H.K., Fernandez-Funez P., Acevedo S.F., et al. Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 2003, 113:457-468.
21. Chen Y.W., Allen M.D., Veprintsev D.B., et al. The structure of the AXH domain of spinocerebellar ataxin-1. J Biol Chem 2004, 279:3758-3765.
22. Chong S.S., McCall A.E., Cota J., et al. Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type1. Nat Genet 1995, 10:344-350.
23. Chung M.Y., Ranum L.P., Duvick L.A., et al. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type1. Nat Genet 1993, 5:254-258.
24. Ciechanover A., Brundin P. The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 2003, 40:427-446.
25. Clark H.B., Burright E.N., Yunis W.S., et al. Purkinje cell expression of a mutant allele of SCA1 in transgenic mice leads to disparate effects on motor behaviors, followed by a progressive cerebellar dysfunction and histological alterations. J Neurosci 1997, 17:7385-7395.
26. Cummings C.J., Mancini M.A., Antalffy B., et al. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat Genet 1998, 19:148-154.
27. Cummings C.J., Reinstein E., Sun Y., et al. Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice. Neuron 1999, 24:879-892.
28. Cummings C.J., Sun Y., Opal P., et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 2001, 10:1511-1518.
29. Currier R.D., Glover G., Jackson J.F., et al. Spinocerebellar ataxia: study of a large kindred. Neurology 1972, 22:1040-1043.
30. Davies S.W., Beardsall K., Turmaine M., et al. Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?. Lancet 1998, 351:131-133. GP.
31. de Chiara C., Menon R.P., Dal Piaz F., et al. Polyglutamine is not all: the functional role of the AXH domain in the ataxin-1 protein. J Mol Biol 2005, 354:883-893.
32. de Chiara C., Menon R.P., Adinolfi S., et al. The AXH domain adopts alternative folds the solution structure of HBP1 AXH. Structure 2005, 13:743-753.
33. DiFiglia M., Sapp E., Chase K.O., et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277:1990-1993.
34. Dragasevic N.T., Culjkovic B., Klein C., et al. Frequency analysis and clinical characterization of different types of spinocerebellar ataxia in Serbian patients. Mov Disord 2006, 21:187-191.
35. Dubourg O., Dürr A., Cancel G., et al. Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. Ann Neurol 1995, 37:176-180.
36. Dürr A., Smadja D., Cancel G., et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies). Clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 1995, 118:1573-1581.
37. Dürr A., Stevanin G., Cancel G., et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol 1996, 39:490-499.
38. Duyckaerts C., Durr A., Cancel G., et al. Nuclear inclusions in spinocerebellar ataxia type 1. Acta Neuropathol (Berl) 1999, 97:201-207.
39. Emamian E.S., Kaytor M.D., Duvick L.A., et al. Serine 776 of ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 2003, 38:375-387.
40. Fernandez-Funez P., Nino-Rosales M.L., de Gouyon B., et al. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 2000, 408:101-106.
41. Filla A., De Michele G., Campanella G., et al. Autosomal dominant cerebellar ataxia type I. Clinical and molecular study in 36 Italian families including a comparison between SCA1 and SCA2 phenotypes. J Neurol Sci 1996, 142:140-147.
42. Filla A., Mariotti C., Caruso G., et al. Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families. Eur Neurol 2000, 44:31-36.
43. Gasser T., Finsterer J., Baets J., et al. EFNS guidelines on the molecular diagnosis of ataxias and spastic paraplegias. Eur J Neurol 2010, 17:179-188.
44. Genis D., Matilla T., Volpini V., et al. Clinical, neuropathologic, and genetic studies of a large spinocerebellar ataxia type 1 (SCA1) kindred: (CAG)n expansion and early premonitory signs and symptoms. Neurology 1995, 45:24-30.
45. Globas C., du Montcel S.T., Baliko L., et al. Early symptoms in spinocerebellar ataxia type 1, 2, 3, and 6. Mov Disord 2008, 23:2232-2238.
46. Goldfarb L.G., Vasconcelos O., Platonov F.A., et al. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol 1996, 39:500-506.
47. Gomez C.M., Thompson R.M., Gammack J.T., et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997, 42:933-950.
48. Gouw L.G., Digre K.B., Harris C.P., et al. Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathologic, and genetic analysis of a large kindred. Neurology 1994, 44:1441-1447.
49. Greenfield J.G. The Spino-cerebellar Degenerations 1954, Charles C Thomas, Springfield, Illinois.
50. Haines J.L., Schut L.J., Weitkamp L.R., et al. Spinocerebellar ataxia in a large kindred: age at onset, reproduction, and genetic linkage studies. Neurology 1984, 34:1542-1548.
51. Harding A.E. The clinical features and classification of the late onset autosomal dominant cerebellar ataxias. Brain 1982, 105:1-28.
52. Hashida H., Goto J., Kurisaki H., et al. Brain regional differences in CAG repeat in the spinocerebellar ataxias: dentatorubral-pallidoluysian atrophy, Machado-Joseph disease, and spinocerebellar ataxia type 1. Ann Neurol 1997, 41:505-511.
53. Holmberg M., Duyckaerts C., Durr A., et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 1998, 7:913-918.
54. Holmes G. An attempt to classify cerebellar disease, with a note on Marie's hereditary cerebellar ataxia. Brain 1907, 30:545-567.
55. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
56. Huynh D.P., Figueroa K., Hoang N., et al. Nuclear localization or inclusion body formation of ataxin-2 are not necessary for SCA2 pathogenesis in mouse or human. Nat Genet 2000, 26:44-50.
57. Ikeda H., Yamaguchi M., Sugai S., et al. Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat Genet 1996, 13:196-202.
58. Illarioshkin S.N., Slominsky P.A., Ovchinnikov I.V., et al. Spinocerebellar ataxia type 1 in Russia. J Neurol 1996, 243:506-510.
59. Infante J., Combarros O., Volpini V., et al. Autosomal dominant cerebellar ataxias in Spain: molecular and clinical correlations, prevalence estimation and survival analysis. Acta Neurol Scand 2005, 111:391-399.
60. Ishikawa K., Fujigasaki H., Saegusa H., et al. Abundant expression and cytoplasmic aggregations of α1A voltage-dependent calcium channel protein associated with neurodegeneration in spinocerebellar ataxia type 6. Hum Mol Genet 1999, 8:1185-1193.
61. Iwabuchi K., Tsuchiya K., Uchihara T., et al. Autosomal dominant spinocerebellar degenerations. Clinical, pathological and genetic correlations. Rev Neurol (Paris) 1999, 155:255-270.
62. Jackson J.F., Currier R.D., Terasaki P.I., et al. Spinocerebellar ataxia and HLA linkage: risk prediction by HLA typing. N Engl J Med 1977, 296:1138-1141.
63. Jana N.R., Zemskov E.A., Wang G., et al. Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release. Hum Mol Genet 2001, 10:1049-1059.
64. Jodice C., Frontali M., Persichetti F., et al. The gene for spinal cerebellar ataxia 1 (SCA1) is flanked by two closely linked highly polymorphic microsatellite loci. Hum Mol Genet 1993, 2:1383-1387.
65. Jodice C., Malaspina P., Persichetti F., et al. Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia 1. Am J Hum Genet 1994, 54:959-965.
66. Jorgensen N.D., Adrensen J.M., Lagalwar S., et al. Phosphorylation of ATX1 at Ser 776 in the cerebellum. J Neurochem 2009, 110:675-686.
67. Juvonen V., Hietala M., Kairisto V., et al. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. Acta Neurol Scand 2005, 111:154-162.
68. Kameya T., Abe K., Aoki M., et al. Analysis of spinocerebellar ataxia type 1 (SCA1)-related CAG trinucleotide expansion in Japan. Neurology 1995, 45:1587-1594.
69. Katsuno M., Adachi H., Kume A., et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 2002, 35:843-854.
70. Kim J.Y., Park S.S., Joo S.I., et al. Molecular analysis of spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7. Mol Cells 2001, 12:336-341.
71. Klement I.A., Skinner P.J., Kaytor M.D., et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 1998, 95:41-53.
72. Klockgether T., Lüdtke R., Kramer B., et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998, 121:589-600.
73. Klostermann W., Zühlke C., Heide W., et al. Slow saccades and other eye movement disorders in spinocerebellar atrophy type 1. J Neurol 1997, 244:105-111.
74. Koeppen A.H. The pathogenesis of spinocerebellar ataxia. Cerebellum 2005, 4:62-73.
75. Koyano S., Iwabuchi K., Yagishita S., et al. Paradoxical absence of nuclear inclusion in cerebellar Purkinje cells of hereditary ataxias linked to CAG expansion. J Neurol Neurosurg Psychiatry 2002, 73:450-452.
76. Kubis N., Dürr A., Gugenheim M., et al. Polyneuropathy in autosomal dominant cerebellar ataxias: phenotype-genotype correlation. Muscle Nerve 1999, 22:712-717.
77. Lam Y.C., Bowman A.B., Jafar-Nejad P., et al. ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127:1335-1347.
78. La Spada A.R. Neurodegeneration: a case of arrested development?. Cell 2006, 127:669-671.
79. La Spada A.R., Taylor J.P. Polyglutamines placed into context. Neuron 2003, 38:681-684.
80. La Spada A.R., Wilson E.M., Lubahn D.B., et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991, 302:77-79.
81. Lee W.Y., Jin D.K., Oh M.R., et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 2003, 60:858-863.
82. Li M., Miwa S., Kobayashi Y., et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 1998, 44:249-254.
83. Lim J., Crespo-Barreto J., Jafar-Nejad P., et al. Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 2008, 452:713-719.
84. Lorenzetti D., Watase K., Xu B., et al. Repeat instability and motor incoordination in mice with a targeted expanded CAG repeat in the Sca1 locus. Hum Mol Genet 2000, 9:779-785.
85. Lunkes A., Gispert S., Enczmann J., et al. Molecular heterogeneity of autosomal dominant cerebellar ataxia: analysis of flanking microsatellites of the spinocerebellar ataxia type 1 locus in a northen European family unequivocally demonstrates non-linkage. Hum Genet 1993, 91:362-366.
86. McCampbell A., Taylor J.P., Taye A.A., et al. CREB-binding protein sequestration by expanded polyglutamine. Hum Mol Genet 2000, 9:2197-2202.
87. McLeod C.J., O'Keefe L.V., Richards R.I. The pathogenic agent in Drosophila models of 'polyglutamine' diseases. Hum Mol Genet 2005, 14:1041-1048.
88. Maschke M., Oehlert G., Xie T.D., et al. Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes. Mov Disord 2005, 20:1405-1412.
89. Matilla T., Volpini V., Genis D., et al. Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG-repeat in a large pedigree displaying anticipation and parental male bias. Hum Mol Genet 1993, 2:2123-2128.
90. Matilla A., Roberson E.D., Banfi S., et al. Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation. J Neurosci 1998, 18:5508-5516.
91. Matilla-Duenas A., Sanchez I., Corral-Juan M., et al. Cellular and molecular pathways triggering neurodegeneration in the spinocerebellar ataxias. Cerebellum 2010, 9:148-166.
92. Michalik A., Van Broeckhoven C. Pathogenesis of polyglutamine disorders: aggregation revisited. Hum Mol Genet 2003, 12:R173-R186. Spec No 2:.
93. Mittal U., Sharma S., Chopra R., et al. Insights into the mutational history and prevalence of SCA1 in the Indian population through anchored polymorphisms. Hum Genet 2005, 118:107-114.
94. Mizutani A., Wang L., Rajan H., et al. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. EMBO J 2005, 24:3339-3351.
95. Molero A.E., Gokhan S., Gonzalez S., et al. Impairment of developmental stem-cell mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington disease. Proc Natl Acad Sci U S A 2009, 106:21900-21905.
96. Moseley M.L., Benzow K.A., Schut L.J., et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 1998, 51:1666-1671.
97. Onodera Y., Aoki M., Tsuda T., et al. High prevalence of spinocerebellar ataxia type 1 (SCA1) in an isolated region of Japan. J Neurol Sci 2000, 178:153-158.
98. Ordway J.M., Tallaksen-Greene S., Gutekunst C.A., et al. Ectopically expressed CAG repeats cause intranuclear inclusions and a progressive late onset neurological phenotype in the mouse. Cell 1997, 91:753-763.
99. Orr H.T., Zoghbi H.Y. SCA1 molecular genetics: a history of a 13 year collaboration against glutamines. Hum Mol Genet 2001, 10:2307-2311.
100. Orr H.T., Chung M., Banfi S., et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 1993, 4:221-226.
101. Pareyson D., Gellera C., Castellotti B., et al. Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes. J Neurol 1999, 246:389-393.
102. Paulson H.L., Perez M.K., Trottier Y., et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997, 19:333-344.
103. Paulson H.L., Das S.S., Crino P.B., et al. Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain. Ann Neurol 1997, 41:453-462.
104. Perutz M.F. Glutamine repeats and inherited neurodegenerative diseases: molecular aspects. Curr Opin Struct Biol 1996, 6:848-858.
105. Pujana M.A., Corral J., Gratacos M., et al. Spinocerebellar ataxias in Spanish patients: genetic analysis of familial and sporadic cases. The Ataxia Study Group. Hum Genet 1999, 104:516-522.
106. Ragno M., Perretti A.C., Castaldo I., et al. Multimodal electrophysiologic follow-up study in 3 mutated but presymptomatic members of a spinocerebellar ataxia type 1 (SCA1) family. Neurol Sci 2005, 26:67-71.
107. Ramocki M.B., Zoghbi H.Y. Failure of neuronal homeostasis results in common neuropsychiatric phenotypes. Nature 2008, 455:912-918.
108. Ranum L.P., Duvick L.A., Rich S.S., et al. Localization of the autosomal dominant HLA-linked spinocerebellar ataxia (SCA1) locus, in two kindreds, within an 8-cm subregion of chromosome 6p. Am J Hum Genet 1991, 49:31-41.
109. Ranum L.P., Chung M.Y., Banfi S., et al. Molecular and clinical correlations in spinocerebellar ataxia type 1 (SCA1): evidence for familial effects on the age at onset. Am J Hum Genet 1994, 55:244-252.
110. Rasmussen A., Yescas P., Matsuura T., et al. Molecular diagnosis of spinocerebellar ataxias in a Mexican population. Am J Hum Genet 2000, 67:342.
111. Reddy P.H., Williams M., Charles V., et al. Behavioural abnormalities and selective neuronal loss in HD transgenic mice expressing mutated full-length HD cdna. Nat Genet 1998, 20:198-202.
112. Robitaille Y., Schut L., Kish S.J. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropathol (Berl) 1995, 90:572-581.
113. Robitaille Y., Lopes-Cendes I., Becher M., et al. The neuropathology of the CAG repeat diseases: review and update of genetic and molecular features. Brain Pathol 1997, 7:901-926.
114. Rolfs A., Koeppen A.H., Bauer I., et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 2003, 54:367-375.
115. Ross C.A. Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders. Neuron 2002, 35:819-822.
116. Sasaki H., Fukazawa T., Yanagihara T., et al. Clinical features and natural history of spinocerebellar ataxia type 1. Acta Neurol Scand 1996, 93:64-71.
117. Scheel H., Tomiuk S., Hofmann K. Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics. Hum Mol Genet 2003, 12:2845-2852.
118. Scherzinger E., Lurz R., Turmaine M., et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997, 90:549-558.
119. Schmidt T., Lindenberg K.S., Krebs A., et al. Protein surveillance machinery in brains with spinocerebellar ataxia type 3: redistribution and differential recruitment of 26S proteasome subunits and chaperones to neuronal intranuclear inclusions. Ann Neurol 2002, 51:302-310.
120. Schmitz-Hübsch T., Coudert M., Bauer P., et al. Spinocerebellar ataxia type 1, 2, 3, and 6. Disease severity and non ataxia symptoms. Neurology 2008, 71:982-989.
121. Schöls L., Amoridis G., Büttner T., et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?. Ann Neurol 1997, 42:924-932.
122. Schöls L., Bauer P., Schmidt T., et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
123. Schut J.W. Hereditary ataxia. Clinical study through six generations. Arch Neurol Psychiatry 1950, 63:535-568.
124. Schut J.W., Haymaker W. Hereditary ataxia: a pathological study of five cases of common ancestry. J Neuropathol Clin Neurol 1951, 1:183-213.
125. Serra H.G., Duvick L., Zu T., et al. RORα-mediated Purkinje cell development determines disease severity in adult SCA1 mice. Cell 2006, 127:697-708.
126. Servadio A., Koshy B., Armstrong D., et al. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat Genet 1995, 10:94-98.
127. Shimizu Y., Yoshida K., Okano T., et al. Regional features of autosomal dominant cerebellar ataxia in Nagano: clinical and molecular genetic analysis of 86 families. J Hum Genet 2004, 49:610-616.
128. Shimohata T., Onodera O., Tsuji S. Expanded polyglutamine stretches lead to aberrant transcriptional regulation in polyglutamine diseases. Hum Cell 2001, 14:17-25.
129. Silveira I., Miranda C., Guimaraes L., et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol 2002, 59:623-629.
130. Sinha K.K., Worth P.F., Jha D.K., et al. Autosomal dominat cerebellar ataxia: SCA2 is the most frequent mutation in eastern India. J. Neurol. Neurosurg. Psychiatry 2004, 75:448-452.
131. Sisodia S.S. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?. Cell 1998, 95:1-4.
132. Skinner P.J., Koshy B.T., Cummings C.J., et al. Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 1997, 389:971-974.
133. Soczak K., Krzyzosiak W.J. Imperfect CAG repeats form diverse structures in SCA1 transcripts. J Biol Chem 2004, 279:41563-41572.
134. Stevanin G., Durr A., Brice A. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet 2000, 8:4-18.
135. Storey E., du Sart D., Shaw J.H., et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet 2000, 95:351-357.
136. Subramony S.H., Currier R.D. The classification of familial ataxias. Hereditary Neuropathies and Spinocerebellar Atrophies 1991, 16(60):271-284. Elsevier, Amsterdam. J.M.B.V. de Jong (Ed.).
137. Takahashi T., Katada S., Onodera O. Polyglutamine diseases: Where does toxicity come from? What is toxicity? Where are we going?. J Mol Cell Biol 2010, 2:180-191.
138. Takano H., Cancel G., Ikeuchi T., et al. Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am J Hum Genet 1998, 63:1060-1066.
139. Tang B., Liu C., Shen L., et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. Arch Neurol 2000, 57:540-544.
140. Taroni F., DiDonato S. Pathways to motor incoordination: the inherited ataxias. Nat Rev Neurosci 2004, 5:641-655.
141. Thompson L.M. A question of balance. Nature 2008, 452:707-708.
142. Trottier Y., Lutz Y., Stevanin G., et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995, 378:403-406.
143. Tsai H.F., Liu C.S., Leu T.M., et al. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol Scand 2004, 109:355-360.
144. Tsuda H., Jafar-Nejad H., Patel A.J., et al. The AXH domain of ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins. Cell 2005, 122:633-644.
145. van de Warrenburg B.P., Sinke R.J., Verschuuren-Bemelmans C.C., et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 2002, 58:702-708.
146. van de Warrenburg B.P., Hendriks H., Dürr A., et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol 2005, 57:505-512.
147. Vierra-Green C.A., Orr H.T., Zoghbi H.Y., et al. Identification of a novel phosphorylation site in ataxin-1. Biochim Biophys Acta 2005, 1744:11-18.
148. Warrick J.M., Chan H.Y., Gray-Board G.L., et al. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat Genet 1999, 23:425-428.
149. Watanabe H., Tanaka F., Matsumoto M., et al. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6. Clin Genet 1998, 53:13-19.
150. Watase K., Weeber E.J., Xu B., et al. A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 2002, 34:905-919.
151. Wu Y.-R., Lee-Chen G.-J., Lang A.E., et al. Dystonia as a presenting sign of spinocerebellar ataxia type 1. Mov Disord 2003, 19:586-587.
152. Wüllner U., Reimold M., Abele M., et al. Dopamine transporter positron emission tomography in spinocerebellar ataxia type 1, 2, 3, and 6. Arch Neurol 2005, 62:1280-1285.
153. Xia H., Mao Q., Eliason S.L., et al. Rnai suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004, 10:816-820.
154. Yakura H., Wakisaka A., Fujimoto S., et al. Hereditary ataxia and HL-A genotypes. N Engl J Med 1974, 291:154-155.
155. Yoo S.Y., Pennesi M.E., Weeber E.J., et al. SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron 2003, 37:383-401.
156. Zoghbi H.Y., Botas J. Mouse and fly models of neurodegeneration. Trends Genet 2002, 18:463-471.
157. Zoghbi H.Y., Orr H.T. Glutamine repeats and neurodegeneration. Annu Rev Neurosci 2000, 23:217-247.
158. Zoghbi H.Y., Orr H.T. Pathogenic mechanisms of a polyglutamine mediated neurodegenerative disease: SCA1. J Biol Chem 2009, 284:7425-7429.
159. Zu T., Duvick L.A., Kaytor M.D., et al. Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci 2004, 24:8853-8861.
160. Zuhlke C., Dalski A., Hellenbroich Y., et al. Spinocerebellar ataxia type 1 (SCA1): phenotype-genotype correlation studies in intermediate alleles. Eur J Hum Genet 2002, 10:204-209.